No Detail Found!

Leonuride protects diabetic nephropathy by activating SREBPs pathway

Author(s)
Lihua Ma The Affiliated Taian City Central Hospital of Qingdao University,Taian,China
Xiaojuan Zhang The Affiliated Taian City Central Hospital of Qingdao University,Taian,China
Yong Li The Affiliated Taian City Central Hospital of Qingdao University,Taian,China
Dongfang Bai The Affiliated Taian City Central Hospital of Qingdao University,Taian,China
Abstract
Diabetic nephropathy (DN), a micro vascular complication of diabetes, is the main cause of end-stage renal disease, with a morbidity over 40% of diabetes. High glucose and lipid metabolism dysfunction are the leading cause of the development of DN. Previous study demonstrated that increased expression or activation of SREBPs in models of DN. Leonuride (LE), as an active constituent of Leonurus japonicus Houttuyn, has multiple biological activities, including antioxidant and anti-inflammatory effects. Previous studies showed that increasing the degradation of mature SREBPs is a robust way of lowering lipids and improve lipid metabolism dysfunction. However, effective regulation method of SREBPs degradation are still lacking. Herein, this study indicated that LE can effectively improve glucose and lipid metabolism disorders. In addition, the kidney function was also improved by inhibition of SREBPs activities in streptozocin (STZ)-induced type II diabetic mice. To our knowledge, this is the first time to describe the detailed mechanism of LE on the inhibition of precursor SREBPs, which would present a new direction for diabetic nephropathy treatment.
Publication Details
Page(s) 65-70
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Diabetic Nephropathy, leonuride, SREBP
0

Citations

0

Downloads

66

Views